Pharmacokinetics and Pharmacodynamic Effects of Different Single Oral Doses of BI 474121 in Healthy Male Subjects
Latest Information Update: 11 Mar 2024
At a glance
- Drugs BI 474121 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 07 Jul 2021 Status changed from active, no longer recruiting to completed.
- 14 Jun 2021 Planned End Date changed from 31 May 2021 to 30 Jun 2021.
- 14 Jun 2021 Planned primary completion date changed from 31 May 2021 to 30 Jun 2021.